GlobalIPNews

Sign Up
|
Login
|

08:37:20 Sun 18 Oct 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Tianjin University

(42)

Shanghai Jiao Tong Univer

(25)

(10)

Hoffmann La Roche [us]; H

(9)

Hoffmann La Roche

(8)

(7)

Shanghai Guangsheng Bioph

(7)

Regeneron Pharmaceuticals

(6)

Ruijin Hospital Shanghai

(6)

Crinetics Pharmaceuticals

(5)

Jiangsu Hengrui Pharmaceu

(5)

Shanghai Qilu Pharmaceuti

(5)

Shenyang Pharmaceutical U

(5)

(4)

China Pharmaceutical Univ

(4)

Eye Hospital WMU

(4)

Guangdong Pharmaceutical

(4)

Innovent Biologics, Suzho

(4)

Institute of Materia Medi

(4)

(4)

Shenzhen Salubris Pharmac

(4)

Tianjin University of Sci

(4)

Tianjin University of Tec

(4)

Zhejiang Meihua Dingchang

(4)

Alterome Therapeutics

(3)

Apex Biosciences Pte Ltd

(3)

Arvinas Operations

(3)

(3)

Atheron Therapeutics Shan

(3)

Axsome Therapeutics

(3)

Boehringer Ingelheim Inte

(3)

Casma Therapeutics

(3)

Changchun Genescience Pha

(3)

Chia Tai Tianqing Pharmac

(3)

Chongqing Lianxin Zhikang

(3)

DSM IP Assets B V

(3)

(3)

Hubei Jishantang Traditio

(3)

(3)

Janssen Pharmaceutica

(3)

Jiangsu Alphamab Biopharm

(3)

Jiangxi University of Tra

(3)

Merck Sharp & Dohme

(3)

(3)

(3)

(3)

ROHTO Pharmaceutical

(3)

Recludix Pharma

(3)

Ringpu Tianjin Bio Pharm

(3)

Sanovel Ilac Sanayi Ve Ti

(3)

Shandong Tianlu Pharmaceu

(3)

State Grid Shanghai Munic

(3)

Tanabe Pharma Corp

(3)

Tsinghua University; Tian

(3)

Vertex Pharmaceuticals

(3)

Yangtze River Pharmaceuti

(3)

Zhejiang Guobang Pharmace

(3)

Agency for Science, Techn

(2)

Alpha Pharmaceutical Co L

(2)

Anhui Meiluo Pharmaceutic

(2)

Antecip Bioventures

(2)

Apeiron Therapeutics Hong

(2)

Arog Pharmaceuticals

(2)

(2)

Beacon Therapeutics Ltd

(2)

Beckley Psytech

(2)

Beijing Tongrentang Healt

(2)

Bohui Biopharmaceutical Y

(2)

Boomray Pharmaceuticals C

(2)

CSPC Zhongqi Pharmaceutic

(2)

(2)

Chengdu Imp Room Jindan P

(2)

China Ocean Shipping Grou

(2)

Chongqing Medical & Pharm

(2)

Chongqing Puyou Biologica

(2)

Daewoong Pharmaceutical

(2)

Daiichi Sankyo Co Limited

(2)

Dangchang Zhenghe Pharmac

(2)

Dezhou Honghai Pharmaceut

(2)

Eisai R&D Management

(2)

Eli Lilly and Company

(2)

Emeishan Tonghui Pharmace

(2)

Fraunhofer Ges Forschung

(2)

Fresenius Kabi Sspc Pharm

(2)

Fudan University

(2)

Genentech Inc [us]; Hoffm

(2)

Genome&company Inc

(2)

Good Doctor Pharmaceutica

(2)

Graviton Pharmaceuticals

(2)

Guangzhou Unirise Pharmac

(2)

Guangzhou University of C

(2)

Hainan Simcere Pharmaceut

(2)

Haisco Pharmaceutical Gro

(2)

Hanhui Pharmaceutical Co

(2)

Hoffmann La Roche [ch]; R

(2)

Hoffmann La Roche [us]; G

(2)

Hoffmann La Roche [us]; H

(2)

Huabo Biopharm Shanghai C

(2)

Hunan Zhuangyuan Pharmace

(2)

(2)

JW Pharmaceutical

(2)

Jiangsu Jianjia Pharmaceu

(2)

Jiangsu Nova Medical Equi

(2)

Jiangxi Xinshengming Phar

(2)

Kobayashi Pharmaceutical

(2)

Kunming University of Sci

(2)

Lanzhou Institute Husband

(2)

Leland Stanford Junior Un

(2)

Meilan Hangzhou Pharmaceu

(2)

Micro Crispr Pvt Ltd

(2)

(2)

Nanjing Zeheng Pharmaceut

(2)

Nankai University

(2)

(2)

Ningxia Jinmei Yinuo Anim

(2)

North China Pharmaceutica

(2)

Onconic Therapeutics Inc

(2)

Pasqal S A S [fr]; Centre

(2)

(2)

Principia Biopharma

(2)

Priovant Therapeutics Inc

(2)

Quanzhou Haichuang Pharma

(2)

Regeneron Pharmaceuticals

(2)

Renji Hospital Shanghai J

(2)

Reunion Neuroscience

(2)

Revopsis Therapeutics Inc

(2)

Shandong Chengchuang Blue

(2)

Shandong Fanhui Biologica

(2)

Shandong Haishan Pharmace

(2)

Shandong New Time Pharmac

(2)

Shandong University

(2)

Shandong University of Tr

(2)

Shanghai Apeiron Therapeu

(2)

Shanghai Chengfan Pharmac

(2)

Shanghai Dongfulong Pharm

(2)

Shanghai Fourth Peoples H

(2)

Shanghai GMS Pharmaceutic

(2)

Shanghai Hanou Pharmaceut

(2)

Shanghai Hansoh Biomedica

(2)

Shanghai Institute of Mat

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jihao Peptide Ph

(2)

Shanghai Kejun Pharmaceut

(2)

Shanghai Shijian Biotechn

(2)

Shanghai Wanshicheng Chin

(2)

Shanghai Yogar Therapeuti

(2)

Shanghai Zaimo Biotechnol

(2)

Sichuan Sunnyhope Pharmac

(2)

Skymab Biotherapeutics

(2)

Sortec Pharma Sortiertech

(2)

Sudo Biosciences

(2)

Sumitomo Pharma

(2)

Suzhou Genepharma Co Ltd

(2)

Tandem Diabetes Care

(2)

The Feinstein Inst For Me

(2)

Tianjin University Medica

(2)

Tianjin University; Huane

(2)

Tpp Jiangsu Co Ltd

(2)

Twenty Twenty Therapeutic

(2)

Unicor Biopharma Ltd

(2)

Unilever Global Ip Ltd [g

(2)

Univ California [us]; U S

(2)

Univ Tianjin [cn]; Tianji

(2)

University Hubei Chinese

(2)

(2)

Wei Chao [cn]; Liu Le [us

(2)

Weichai Power; Tianjin Un

(2)

Weihai Jinyiyang Pharmace

(2)

Zhejiang Huakang Pharmace

(2)

Zhejiang Pharmaceutical V

(2)

Abaxys Therapeutics

(1)

Abbisko Therapeutics

(1)

Abbott Lab [us]; Abbott L

(1)

Accendatech Co Ltd

(1)

Ache Laboratorios Farmace

(1)

Actio Biosciences Inc

(1)

(1)

(1)

Aethlon Medical Inc

(1)

Affiliated Hospital of Qi

(1)

Affiliated Hospital of Sh

(1)

Agenebio Inc [us]; Johns

(1)

Akebia Therapeutics

(1)

Akore Formulations Privat

(1)

Aksu Prefecture Uygur Med

(1)

Aleksia Therapeutics Inc

(1)

Alexion Pharmaceuticals

(1)

(1)

Allen Joshua Edward [us];

(1)

(1)

Allibre Animal Llc

(1)

Alpha 9 Oncology Inc

(1)

Alpha Cognition

(1)

Amgen Research (Munich)

(1)

Amylyx Pharmaceuticals In

(1)

Anbogen Therapeutics Usa

(1)

Anhui Gufatang Biological

(1)

Anhui Libo Pharmaceutical

(1)

Anhui Menovo Pharmaceutic

(1)

Anhui University of Chine

(1)

Anhui Xingen Pharmaceutic

(1)

Anhui Yuanhetang Pharmace

(1)

Anhui Zhihuo Pharmaceutic

(1)

Anipha Technologies

(1)

Annexin Pharmaceuticals A

(1)

Anyang Yuanshou Biologica

(1)

Aop Orphan Pharmaceutical

(1)

Aphaia Pharma Ag

(1)

Apmonia Therapeutics Inc

(1)

Armata Pharmaceuticals

(1)

Army Medical University

(1)

Arnatar Therapeutics Inc

(1)

Artiva Biotherapeutics In

(1)

Ascentage Pharma Suzhou C

(1)

Ascletis Pharma China Co

(1)

Aspid Pharma S A De C V

(1)

Assia Chemical Industries

(1)

Astellas Gene Therapies

(1)

Astellas Pharma

(1)

Astrazeneca Uk Ltd [gb];

(1)

Atai Therapeutics

(1)

Atom High Tech North Chin

(1)

Aurisco Pharmaceutical Ti

(1)

Auron Therapeutics Inc

(1)

Auson Pharmaceuticals

(1)

Ausper Biopharma Co Ltd [

(1)

(1)

Axonis Therapeutics Inc

(1)

Azurity Pharmaceuticals

(1)

Bactheravax B V

(1)

Bactopharma Gmbh

(1)

Baichenghao Biological Ph

(1)

Bailinke Pharmaceutical T

(1)

Baoding Traditional Chine

(1)

Basilea Pharmaceutica Int

(1)

Bdr Pharmaceuticals Inter

(1)

Beam Therapeutics

(1)

Beijing Collab Pharma Co

(1)

Beijing Continent Pharmac

(1)

Beijing Fresenius Kabi Ph

(1)

Beijing Friendship Hospit

(1)

Beijing Gene Plus Medical

(1)

Beijing Giluntide Pharmac

(1)

Beijing Hexin Pharmaceuti

(1)

Beijing Huafang Tianshi B

(1)

Beijing Jingyi Hesheng Ph

(1)

Beijing Juzhi Fuze Biotec

(1)

Beijing Kangyuanxiangrui

(1)

Beijing Mingxi Zhijian Me

(1)

Beijing Percutek Therapeu

(1)

Beijing Pharmaceutical Ra

(1)

Beijing Tide Pharmaceutic

(1)

Beijing Tong Ren Tang Gro

(1)

Beijing Tongrentang Sichu

(1)

Beijing University

(1)

Beijing University of Chi

(1)

Beijing Yanshou Health Te

(1)

Beijing Yuanfang Tongda P

(1)

Beijing Zhipei Linghang W

(1)

Beren Therapeutics P B C

(1)

(1)

Beyang Therapeutics

(1)

BeyondSpring Pharmaceutic

(1)

(1)

(1)

(1)

Biohaven Therapeutics Ltd

(1)

(1)

Boai NKY Pharmaceuticals

(1)

Boehringer Ingelheim Int

(1)

Boehringer Ingelheim Vetm

(1)

Bold Therapeutics

(1)

Bozhou Public Inspection

(1)

Bracco Imaging SpA

(1)

Braun Melsungen

(1)

Brio Pharmaceuticals Inc

(1)

Brise Pharmaceuticals Co

(1)

Bristol Myers Squibb

(1)

C N C C S S C A R L Colle

(1)

C2r Global Mfg Inc

(1)

CR Sanjiu Zaozhuang Pharm

(1)

CRISPR Therapeutics

(1)

CSPC Megalith Biopharmace

(1)

CSSC Power Institute; Tia

(1)

Cadrenal Therapeutics Inc

(1)

Canciobello Echevarria Al

(1)

Cangzhou Medical College

(1)

Capital Medical Univ

(1)

Case Western Reserve Univ

(1)

Catena Biosciences Inc

(1)

Ceinge Biotecnologie Avan

(1)

Celagenex Res India Pvt L

(1)

Celestial Therapeutics In

(1)

(1)

Centre Leon Berard [fr];

(1)

Centrum Badan Molekularny

(1)

Cerbios Pharma Sa

(1)

Cerebro Pharma Inc

(1)

Certa Therapeutics

(1)

Cevec Pharmaceuticals

(1)

(1)

Changchun Dirui Pharmaceu

(1)

Changxing Pharmaceutical

(1)

Changzhou Chunlai Pharmac

(1)

Changzhou Fubang Biologic

(1)

Changzhou Ruiming Pharmac

(1)

Changzhou Yinsheng Pharma

(1)

Channavix Therapeutics Ll

(1)

Chemclin Diagnostics Corp

(1)

(1)

Chengdu Bailiduote Biolog

(1)

Chengdu Gowell Biopharmac

(1)

Chengdu Haitai Pharmaceut

(1)

Chengdu Jiabao Yaoyin Pha

(1)

Chengdu Jiankang Pharmace

(1)

Chengdu Jingxi Pharmaceut

(1)

Chengdu Jiuzhitang Jindin

(1)

Chengdu University of Tra

(1)

Chengdu Zenitar Biomedica

(1)

Chiesi Farmaceutici

(1)

Children\'s Hospital of F

(1)

Children\'s Medical Cente

(1)

Childrens Hospital Of Soo

(1)

China Resources Jiangzhon

(1)

China Resources Zizhu Pha

(1)

China State Inst Of Pharm

(1)

Chongqing Conquer Pharmac

(1)

Chongqing Jiangxia Bioche

(1)

Chongqing Kerui Pharmaceu

(1)

Chongqing Naoji Medical T

(1)

Chongqing Peidu Pharmaceu

(1)

Chongqing Traditional Chi

(1)

Chongqing University; Sha

(1)

Chongqing Zhicheng Pharma

(1)

Christian Albrechts Univ

(1)

Chugai Pharmaceutical

(1)

Chuxiong Lao Bo Yun Tang

(1)

Cinclus Pharma Holding AB

(1)

City Therapeutics Inc

(1)

Ck Life Sciences Developm

(1)

Clegg Richard Ian [gb]; A

(1)

Coave Therapeutics

(1)

Columbia University; Rens

(1)

Contineum Therapeutics

(1)

Corbus Pharmaceuticals

(1)

Corner Therapeutics

(1)

Corrugated Therapeutics C

(1)

Corvia Medical Inc

(1)

Council of Scientific & I

(1)

Cour Pharmaceuticals Deve

(1)

Crane Trask [us]; Inan Om

(1)

Crossbow Therapeutics Inc

(1)

Crystal Pharmatech Co Ltd

(1)

Cspc Baike Shandong Biolo

(1)

Cstone Pharmaceuticals [g

(1)

Curofin Pharma Gmbh

(1)

Cydex Pharmaceuticals Inc

(1)

Dali Animal Husbandry And

(1)

Dana-Farber Cancer Instit

(1)

Dartmouth College [us]; T

(1)

Dasan Pharmaceutical Co L

(1)

Deep Eigenmatics Inc [us]

(1)

Delta Fly Pharma Inc

(1)

Denali Therapeutics

(1)

(1)

Domain Therapeutics

(1)

(1)

Dongguan Asia Pharmaceuti

(1)

Dongguan Gushengtang Phar

(1)

Dr Reddy\'s Laboratories

(1)

Dragonboat Biopharmaceuti

(1)

Dynamic Therapeutics Ltd

(1)

ENSEM Therapeutics

(1)

Egyt Gyogyszervegyeszeti

(1)

Eikon Therapeutics

(1)

Elanco Us Inc [us]; Salk

(1)

Eledon Pharmaceuticals

(1)

Elkabbany Amr Ibrahim [us

(1)

(1)

Enanta Pharmaceuticals

(1)

Endolipid Therapeutics S

(1)

(1)

Equashield Medical

(1)

(1)

Evonik Operations

(1)

Ewts Di Federica Ragni

(1)

Exam Therapeutics Inc

(1)

Exeliris [cn]; Lin Gang L

(1)

Eye Hospital of China Aca

(1)

(1)

Face Reality Llc

(1)

(1)

Faron Pharmaceuticals Oy

(1)

(1)

Feng Lei [cn]; Alterome T

(1)

(1)

(1)

First Affiliated Hospital

(1)

First Affiliated Hospital

(1)

First People\'s Hospital

(1)

Flagship Pioneering Innov

(1)

Flare Therapeutics

(1)

Foghorn Therapeutics

(1)

Foshan Nanhai People\'s H

(1)

Fourth Hospital of Hebei

(1)

Fresenius Kabi USA

(1)

Fujian Fuchengrun Biotech

(1)

Fujian Fukang Pharmaceuti

(1)

Fujian Haixia Technology

(1)

Fujian Sairui Pharmaceuti

(1)

Fujifilm Corp [jp]; FUJIF

(1)

Fullhope Biomedical

(1)

Fundacion De La Comunidad

(1)

Fuxing Antejin Chengdu Bi

(1)

Fuyang Women and Children

(1)

Fuzhou Medical Univ

(1)

Fuzhou Yuejian Tech Co Lt

(1)

(1)

Gaal Peter [us]; Zheng Ru

(1)

Ganzhou Hemay Pharmaceuti

(1)

Gao Haijing; Liu Weiji

(1)

(1)

Gea Pharma Systems Ltd

(1)

Gelnova Laboratories Indi

(1)

Gemvax & Kael Co Ltd

(1)

Geneiii Biotech Co Ltd

(1)

Genentech; Hoffmann La Ro

(1)

Genequantum Healthcare Su

(1)

Genequantum Healthcare Su

(1)

(1)

Genzyme Corporation

(1)

Gi Longevity Inc

(1)

Gilead Sciences

(1)

Gilva Therapeutics Co Ltd

(1)

(1)

Global Blood Therapeutics

(1)

Goa Therapeutics Corp

(1)

Golden Phoenix Laboratory

(1)

(1)

Grugene Therapeutics Inc

(1)

Guangdong Chunhua Pharmac

(1)

Guangdong Lingdong Pharma

(1)

Guangdong Maternal and Ch

(1)

Guangdong Province Pharma

(1)

Guangdong Sinocorp Pharma

(1)

Guangdong Tengjun Pharmac

(1)

Guangxi Liugang Medical C

(1)

Guangxi Univ Of Chinese M

(1)

Guangxi Zhuang Autonomous

(1)

Guangzhou Aoyue Chinese M

(1)

Guangzhou Baokang Pharmac

(1)

Guangzhou Bio Gene Tech C

(1)

Guangzhou Dongyuan Pharma

(1)

Guangzhou Hanfang Pharmac

(1)

Guangzhou Hanguang Pharma

(1)

Guangzhou Hejiarunyan Pha

(1)

Guangzhou Huamei Pharmace

(1)

Guangzhou Hurui Pharmaceu

(1)

Guangzhou Jianqi Electron

(1)

Guangzhou Jierkang Pharma

(1)

Guangzhou Jike Pharmaceut

(1)

Guangzhou Kangsheng Pharm

(1)

Guangzhou Liantian Pharma

(1)

Guangzhou Longest Medical

(1)

Guangzhou National Labora

(1)

Guangzhou Wanglaoji Pharm

(1)

Guangzhou Zhongxing Sport

(1)

Guizhou Didao Pharmaceuti

(1)

Guizhou Diyi Health Pharm

(1)

Guizhou Jingcheng Pharmac

(1)

Guizhou Jingzheng Pharmac

(1)

Guizhou Shenqi Pharmaceut

(1)

Guizhou Weikang Zifan Pha

(1)

Guizhou Zuoli Machinery T

(1)

Guokongda Health Tech Sha

(1)

Guoyaojituan Tongjitang G

(1)

Guoyuan Guoyao Guangdong

(1)

Guyitang Health Tech Grou

(1)

Gwangju Inst Of Science A

(1)

Hainan Changan Int Pharma

(1)

Hainan Hualon Pharmaceuti

(1)

Hainan Jinrui Pharmaceuti

(1)

Haisco Pharmaceutical Gro

(1)

Halda Therapeutics OpCo

(1)

Halyard Therapeutics [us]

(1)

Hangzhou Bangshun Pharmac

(1)

Hangzhou Fst Pharmaceutic

(1)

Hangzhou Glubio Pharmaceu

(1)

Hangzhou Hospital of Trad

(1)

Hangzhou Jujiu Science &

(1)

Hangzhou Medical College

(1)

Hangzhou Sidate Biotechno

(1)

Hangzhou Synrx Therapeuti

(1)

Hangzhou Yirui Pharmaceut

(1)

Hanmi Pharmaceutical

(1)

Harbin Inst Of Technology

(1)

Harbin Inst Of Technology

(1)

Harbin Medical University

(1)

Harold Tom [us]; Nussbaum

(1)

Hebei Anlin Pharmaceutica

(1)

Hebei Daoen Pharmaceutica

(1)

Hebei Kangzheng Pharmaceu

(1)

Hebei Provincial Hospital

(1)

Hebei Shengxue Dacheng Ph

(1)

Hebei Xinranyu Pharmaceut

(1)

Heilongjiang Bayi Agricul

(1)

Heilongjiang Dinuo Pharma

(1)

Heilongjiang Hanxing Expe

(1)

Heilongjiang Tengde Pharm

(1)

Helmholtz Zentrum Dresden

(1)

Henan Bifu Pharmaceutical

(1)

Henan Huafeng Pharmacy Co

(1)

Henan Rongchang Pharmaceu

(1)

Henan University of Chine

(1)

Henan Yushengtang Pharmac

(1)

Heronova Pharmaceuticals

(1)

Heya Beijing Pharmaceutic

(1)

Heya Beijing Pharmaceutic

(1)

Histone Therapeutics Corp

(1)

Hoffmann La Roche [ch]; R

(1)

Hoffmann La Roche [ch]; R

(1)

Hoffmann La Roche [us]; G

(1)

Hong Kong King Friend Ind

(1)

Honghua Beijing Tech Co L

(1)

Hope City [us]; Wayne Sta

(1)

Hospital Affiliated To Fu

(1)

HotSpot Therapeutics

(1)

Huahai Tianheng Shanghai

(1)

Huangshi Shixing Pharmace

(1)

Huapu Shijiazhuang Pharma

(1)

Hubei Bio Pharmaceutical

(1)

Hubei Gedian Humanwell Ph

(1)

Hubei Shike Pharmaceutica

(1)

Hubei Tiancheng Chinese H

(1)

Hubei Yitai Pharmacy Co L

(1)

Hubei Yusheng Water Eng C

(1)

Huiankai Xiamen Pharmaceu

(1)

Huidagene Therapeutics (S

(1)

Hunan University

(1)

Hunan Wugan Pharmaceutica

(1)

Hunan Zhengzhong Pharmace

(1)

Huzhou Normal Univ

(1)

(1)

Icosagen Cell Factory Oue

(1)

Idorsia Pharmaceuticals

(1)

(1)

Imbioray Hangzhou Biomedi

(1)

Immunecare Biopharmaceuti

(1)

Immutrix Therapeutics Inc

(1)

Impact Therapeutics Inc

(1)

(1)

Innocure Therapeutics Inc

(1)

Innomedica Holding Ag

(1)

Innovative Scient Product

(1)

Insilico Medicine

(1)

Inst Curie [fr]; Centre N

(1)

Inst Fuer Laborwissenscha

(1)

Inst Fuer Luft Und Kaelte

(1)

Inst Of Applied Mathemati

(1)

Institute of Animal Scien

(1)

Institute of Biophysics,

(1)

Institute of Chemistry, C

(1)

Institute of Chinese Mate

(1)

Institute of Materia Medi

(1)

Institute of Materia Medi

(1)

Insulet Corporation

(1)

Intas Pharmaceuticals

(1)

Integrative Res Laborator

(1)

Intra-Cellular Therapies

(1)

Intract Pharma Ltd

(1)

(1)

Iucf Hyu [kr]; Korea Adva

(1)

(1)

Janux Therapeutics

(1)

Jazz Pharmaceuticals Irel

(1)

Jia Yinhua [cn]; Wei Chao

(1)

Jiale Shandong Holdings C

(1)

Jiangnan University

(1)

Jiangsu Baozong & Baoda P

(1)

Jiangsu Biojetay Biotechn

(1)

Jiangsu Deyuan Pharm Co L

(1)

Jiangsu Haorun Biological

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Hongtai Pharmaceu

(1)

Jiangsu Jiaerke Pharmaceu

(1)

Jiangsu Ocean University;

(1)

Jiangsu Province Hospital

(1)

Jiangsu Provincial Center

(1)

Jiangsu Provincial Xuzhou

(1)

Jiangsu Simcere Pharmaceu

(1)

Jiangsu Southeast Nano Ma

(1)

Jiangsu Targetpharma Labo

(1)

Jiangsu Tasly Diyi Pharma

(1)

Jiangsu Tiansheng Pharmac

(1)

Jiangsu Vcare Pharmatech

(1)

Jiangsu Xietong Pharmaceu

(1)

Jiangsu Xinglin Pharmaceu

(1)

Jiangsu Youyang Pharmaceu

(1)

Jiangxi Fengyuan Ecologic

(1)

Jiangxi Kvvit Pharmaceuti

(1)

Jiangxi Lishikaoxian Zhul

(1)

Jiangxi Provincial Inst O

(1)

Jiangxi Tengwangge Pharma

(1)

Jiangxi University of Tra

(1)

Jiangxi Xiangtai Life Sci

(1)

Jiangxi Zhangbang Pharmac

(1)

Jiangyou Pharmaceutical C

(1)

Jiaozuo Minkang Pharmaceu

(1)

Jiaozuo Zhongwei Special

(1)

Jiaxing Fabo Xintian Phar

(1)

Jilin Aodong Yanbian Phar

(1)

Jilin Baishan Zhengmao Ph

(1)

Jilin Tongzhen Medicine C

(1)

Jilin University

(1)

Jingbian Yishengkang Agri

(1)

Jingmen Central Hospital

(1)

Jinhao Pharmaceutical Sha

(1)

Jining Ankang Pharmaceuti

(1)

Jinpai Chizhengtang Pharm

(1)

Jinzhong Vocational & Tec

(1)

Jiuwei Zhejiang Network T

(1)

Joincare Pharmaceutical G

(1)

Jrd Science Inc

(1)

(1)

Julius Maximilians Univer

(1)

Kaimisite Henan Pharmaceu

(1)

(1)

Kaiping Dahao Daily Chemi

(1)

Kaiping Genuine Biochemic

(1)

Kangbaida (Sichuan) Biote

(1)

Kanggu Minimally Invasive

(1)

Katalick Pharmaceuticals

(1)

Katmai Pharmaceuticals In

(1)

Kelly Ryan Lewis [us]; Le

(1)

Key Knock Biopharmaceutic

(1)

Keymed Biosciences Co Ltd

(1)

Kindeva Drug Delivery

(1)

Kindos Pharmaceuticals

(1)

Kinetiq Therapeutics Llc

(1)

King S College London [gb

(1)

Kite Therapeutics Inc

(1)

Kither Biotech S R L

(1)

Koerber Pharma Inspection

(1)

Koleebox (Suzhou) Intelli

(1)

Korea Inst Ocean Sci & Te

(1)

Kos Therapeutics Inc [us]

(1)

Kpc Pharmaceuticals Inc

(1)

Kunming Institute of Zool

(1)

Kunming Medical Universit

(1)

Kunming Medical Universit

(1)

Kwizda Pharma Gmbh

(1)

Kymera Therapeutics

(1)

LTS Lohmann Therapie-Syst

(1)

Laboratorio Biologico De

(1)

Laboratorio Farm C T S R

(1)

Ladder Therapeutics Inc

(1)

Lahjavida Inc [us]; Lahja

(1)

Lalezari Jacob [us]; Pest

(1)

Lanzhou Industry Research

(1)

Lanzhou Institute of Chem

(1)

Leaderna Therapeutics Ltd

(1)

Lee Hee Jun [us]; Kwong G

(1)

(1)

Lee Pharma Ltd [in]; Vasc

(1)

Leidos Biomedical Res Inc

(1)

Lexicon Pharmaceuticals

(1)

Lianwu Jinnuo Shanghai Bi

(1)

Lianyungang Animal Produc

(1)

Lianyungang Kaiheng Pharm

(1)

Liaocheng University

(1)

Liaoning Daxiong Pharmace

(1)

Liqmeds Worldwide

(1)

Lishen Pharmaceutical Jil

(1)

Lisheng Pharmaceutical Su

(1)

Longyan University

(1)

Lubrizol Advanced Materia

(1)

(1)

(1)

Luoyang Shaoyao Medical S

(1)

(1)

Lushan County Donghai Bre

(1)

Lycia Therapeutics

(1)

Maco Pharma [fr]; Maco Ph

(1)

Mallinckrodt Pharmaceutic

(1)

Maoming Green Chemical Re

(1)

Massey Ventures Ltd [nz];

(1)

(1)

Medici Therapeuticals Inc

(1)

(1)

Medinno Pharmceutical Xia

(1)

Meiji Holdings Co Ltd

(1)

Meixin Jiazhongwei Pharma

(1)

(1)

Metagen Inc [jp]; Kanagaw

(1)

Metrio Pharmaceuticals In

(1)

Mianyang Aopai Tech Co Lt

(1)

Miaodatong Zhejiang Biote

(1)

Mingji Xian Biotechnology

(1)

Mingjin Biotechnology Co

(1)

Minoryx Therapeutics S L

(1)

Minsheng Zhongke Jiayi Sh

(1)

(1)

Modern Chinese Medicine H

(1)

Modiblast Pharma Gmbh

(1)

Momenta Pharmaceuticals

(1)

Momentum Therapeutics Inc

(1)

Monte Rosa Therapeutics

(1)

Mt Medicals Limited Liabi

(1)

Muen Pharmaceutical Equip

(1)

Mufeile Medical Tech Suzh

(1)

Murray And Poole Entpr Lt

(1)

Myris Therapeutics Inc

(1)

Nanchang Hangkong Univers

(1)

Nanchang Medical Universi

(1)

Nanchang University

(1)

Nanhai Beisha Pharmaceuti

(1)

Nanjing Bodeli Biotechnol

(1)

Nanjing Chia-Tai Tianqing

(1)

Nanjing Chuxingtang Pharm

(1)

Nanjing Dajing Tcm Inform

(1)

Nanjing Deyuan Pharmaceut

(1)

Nanjing Haoyutong Pharmac

(1)

Nanjing Hospital of Tradi

(1)

Nanjing Huaxing Medical T

(1)

Nanjing Jisheng Aoma Biol

(1)

Nanjing King Friend Bioch

(1)

Nanjing Leading Medical T

(1)

Nanjing Linkinovo Biologi

(1)

Nanjing Poertai Biotechno

(1)

Nanjing Qinling Medicine

(1)

Nanjing Ruike Health Phar

(1)

Nanjing Sanhome Pharmaceu

(1)

Nanjing University of Chi

(1)

Nanjing University of Chi

(1)

Nanjing Zaiming Pharmaceu

(1)

Nanjing Zhihe Medicine Te

(1)

NanoVation Therapeutics

(1)

Nanobiotix Nanobiotix S A

(1)

Nanocopoeia Llc [us]; Fle

(1)

Nanovish Therapeutics Inc

(1)

Nanping Borui Medical Lab

(1)

Nanyang Biologics Pte Ltd

(1)

Nanyang Wancaotang Pharma

(1)

Nat Cerebral & Cardiovasc

(1)

Nat Univ Singapore [sg];

(1)

Nat Univ Singapore [sg];

(1)

(1)

National Inst Of Biomedic

(1)

National Univ Corporation

(1)

Naval Medical University

(1)

Navigo Proteins

(1)

Neuregen Therapeutics Suz

(1)

Nextage Therapeutics Ltd

(1)

Nganga Kevin [us]; Cai Xi

(1)

Ningbo City Yinzhou Distr

(1)

Ningbo Combireg Pharmaceu

(1)

Ningbo Jiangbei Ruijing M

(1)

Ningbo Sailefu Sheet Mate

(1)

Ningbo Xijian Pharmaceuti

(1)

Ningbo Xingboyuan Intelli

(1)

Ningxia Hui Autonomous Re

(1)

Nippon Shinyaku

(1)

(1)

Northwest Normal Universi

(1)

Northwestern University

(1)

Noterdaeme Timothee

(1)

Noucor Health S A [es]; I

(1)

Novalabs Therapeutics Llc

(1)

Novartis France

(1)

(1)

Nuoqiao Pharmaceutical Ch

(1)

Nuphase Therapeutics Shan

(1)

(1)

Nutropharma Spolka Z Ogra

(1)

Nuvig Therapeutics Inc

(1)

(1)

OMRON Tateisi Electronics

(1)

ORIC Pharmaceuticals

(1)

Ocean University China

(1)

Ocular Therapeutix

(1)

Oncopia Therapeutics Inc

(1)

Oncoprecision Corp

(1)

(1)

One Biosciences [fr]; Rou

(1)

Ong Teng Jin [us]; Genmab

(1)

(1)

Orbicular Pharmaceutical

(1)

Oreal [fr]; Anne Potter [

(1)

Orionis Biosciences Bv [b

(1)

Osiris Therapeutics

(1)

Otsuka Pharma Co Ltd [jp]

(1)

Otto Von Guericke Univ Ma

(1)

Oujiang Laboratory

(1)

Overseas Pharmaceuticals

(1)

Oz Medicann Group Pty Ltd

(1)

PLA Air Force Medical Uni

(1)

PTC Therapeutics

(1)

Padarn Therapeutics Inc

(1)

Para Therapeutics Inc [us

(1)

Peroxitech Therapeutics I

(1)

Pharma Res Bio Co Ltd

(1)

Pharmaceutical Works Polp

(1)

Pharmaengine Inc

(1)

(1)

Phia Biopharmaceuticals I

(1)

Phio Pharmaceuticals Corp

(1)

Pivot Therapeutics Inc

(1)

(1)

Pliant Therapeutics

(1)

Porton Pharma Solutions

(1)

Poseida Therapeutics

(1)

Precede Biosciences Inc

(1)

Prelude Therapeutics

(1)

Previpharma Gmbh

(1)

Prime Gene Therapeutics

(1)

Prism Sciences Llc

(1)

Progen Co Ltd [kr]; Rani

(1)

Prometheus Therapeutics

(1)

(1)

Purdue Research Foundatio

(1)

Purecircle Sdn Bhd

(1)

Purespring Therapeutics L

(1)

Puyang Huiyuan Pharmaceut

(1)

Pyunkang Korean Medicine

(1)

Qide Pharmaceutical Tech

(1)

Qilu Pharmaceutical

(1)

Qilu Puget Sound Biothera

(1)

Qingdao Awyeth Biopharmac

(1)

Qingdao Baheal Pharmaceut

(1)

Qingdao Haihui Biochemica

(1)

Qinghai Shuliao Intellige

(1)

Qinghua Deren Xian Xingfu

(1)

Qinhuangdao Daen Pharmace

(1)

Qubit Pharmaceuticals

(1)

Qufu New Element Biologic

(1)

Quoin Pharmaceuticals Inc

(1)

Qureshi Adnan I

(1)

Quzhou Weirong Pharmaceut

(1)

Ratio Therapeutics Inc

(1)

Re Use Therapeutics Inc

(1)

Recerise Therapeutics Inc

(1)

Recurium IP Holdings

(1)

Recursion Pharmaceuticals

(1)

Red Heart Pharmaceutical

(1)

Regeneron Pharma [us]; Sa

(1)

Regeneron Pharma [us]; Se

(1)

Regents of the University

(1)

Renji Hospital Shanghai J

(1)

Repare Therapeutics

(1)

Repertoire Immune Medicin

(1)

Revolo Biotherapeutics Lt

(1)

Riboway Therapeutics Inc

(1)

Rincon Therapeutics Inc

(1)

Rohto Pharma [jp]; Centre

(1)

Rongchang Pharmaceutical

(1)

Ruibo Suzhou Pharmaceutic

(1)

Ruijin Hospital Shanghai

(1)

SPR Therapeutics

(1)

Sage Therapeutics Llc

(1)

Samsung Life Public Welfa

(1)

(1)

Sanofi Vaccines Us Inc

(1)

Sanofi [fr]; Sanofi

(1)

Santen Pharmaceutical

(1)

Sartorius Stedim Cellca

(1)

Seinda Pharmaceutical Gua

(1)

Seran Bioscience Llc

(1)

Serina Therapeutics Al In

(1)

Shaanxi Baofang Tech Co L

(1)

Shaanxi Jishi Kangyuan Ph

(1)

Shaanxi Mebo Disinfection

(1)

Shaanxi Normal University

(1)

Shaanxi Traditional Chine

(1)

Shaanxi Xingfudao Smart T

(1)

Shandong Academy of Pharm

(1)

Shandong Anhong Pharmaceu

(1)

Shandong Bestcomm Pharmac

(1)

Shandong College Traditio

(1)

Shandong College Traditio

(1)

Shandong Erye Pharmaceuti

(1)

Shandong Heqi Pharmaceuti

(1)

Shandong Huangshengtang P

(1)

Shandong Huanong Biologic

(1)

Shandong Jincheng Bio Pha

(1)

Shandong Jiulong Xinhe Ph

(1)

Shandong Lukang Pharmaceu

(1)

Shandong Luye Pharmaceuti

(1)

Shandong Nerve Pharm Flui

(1)

Shandong Nuomingkang Phar

(1)

Shandong Pharmaceutical I

(1)

Shandong SMA Pharmatech

(1)

Shandong Sbond Pharmaceut

(1)

Shandong Simcere Zaiming

(1)

Shandong Tianyu Biologica

(1)

Shandong Tongxing Pharmac

(1)

Shandong University of Tr

(1)

Shandong WEGO Prefills Ph

(1)

Shandong Xijunkang Pharma

(1)

Shandong Yunxing Pharmace

(1)

Shandong Zhengtian Medica

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai Argo Biopharmace

(1)

Shanghai Aryl Pharmtech C

(1)

Shanghai Boteng Zhihui Bi

(1)

Shanghai Changshousong Ph

(1)

Shanghai Changxing Ocean

(1)

Shanghai Chaoyang Pharmac

(1)

Shanghai East Hospital To

(1)

Shanghai East Hospital To

(1)

Shanghai EpimAb Biotherap

(1)

Shanghai Fosun Pharmaceut

(1)

Shanghai Hailu Biological

(1)

Shanghai Haiyan Pharmaceu

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hemo Pharmaceuti

(1)

Shanghai Hongli Pharmaceu

(1)

Shanghai Hospital Traditi

(1)

Shanghai Huike Biopharmac

(1)

Shanghai Huilun Pharmaceu

(1)

Shanghai Inst Of Biomedic

(1)

Shanghai Inst Of Organic

(1)

Shanghai Jiading Nanxiang

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jingan Tradition

(1)

Shanghai Kangabio Co Ltd

(1)

Shanghai Kunbo Jiurui Pha

(1)

Shanghai Kygent Pharmaceu

(1)

Shanghai Leichang Tech Co

(1)

Shanghai Lishan Biologica

(1)

Shanghai Lixin Lianchuang

(1)

Shanghai Minwei Biotechno

(1)

Shanghai Pharmaceuticals

(1)

Shanghai Qilu Pharmaceuti

(1)

Shanghai Scizeng Medical

(1)

Shanghai Shengpu Zetai Ph

(1)

Shanghai Symray Biopharma

(1)

Shanghai Syntheall Pharma

(1)

Shanghai Tongren Pharmace

(1)

Shanghai Traditional Chin

(1)

Shanghai Weizhenzi Biotec

(1)

Shanghai Wennai Therapeut

(1)

Shanghai Xianduo Chemical

(1)

Shanghai Yanfu Pharmaceut

(1)

Shanghai Yaoming Bio Medi

(1)

Shanxi Medical University

(1)

Shanxi Pharmaceutical Voc

(1)

Shanxi Piang Pharmaceutic

(1)

Shanxi Rendetang Medicine

(1)

Shanxi Ruixiang Biologica

(1)

Shaoxing Jingxin Pharmace

(1)

Shaoxing Keqiao Research

(1)

Shenyang Orthopaedic Hosp

(1)

Shenyang Sinqi Pharmaceut

(1)

Shenzhen City Ruixun Auto

(1)

Shenzhen Daguang Sensing

(1)

Shenzhen Hospital of Sout

(1)

Shenzhen Oralead Pharma C

(1)

Shenzhen Research Inst Of

(1)

Shenzhen Shankang Pharmac

(1)

Shenzhen Shulin Biomedica

(1)

Shenzhen Telike Tech Co L

(1)

Shenzhen University

(1)

Shenzhen Xinrui Gene Tech

(1)

Shihezi University

(1)

Shihezi University; Zhong

(1)

Shijiazhuang Fengqiang An

(1)

Shijiazhuang Yiling Pharm

(1)

Shinkei Therapeutics

(1)

Shiyan Wudang Shenai Biot

(1)

Sichuan Guoqiang Traditio

(1)

Sichuan Huiyu Pharmaceuti

(1)

Sichuan Luhui Pharmaceuti

(1)

Sichuan Pharmaceutical

(1)

Sichuan Provincial People

(1)

Sichuan Senke Pharmaceuti

(1)

Sigilon Therapeutics

(1)

Silexion Therapeutics Ltd

(1)

Silicopharm Inc [kr]; Dae

(1)

Simcere Pharmaceutical Co

(1)

Simcere Pharmaceutical Co

(1)

Simcere Zaiming Pharmaceu

(1)

Simtra Us Llc D/b/a Simtr

(1)

Singapore Health Serv Pte

(1)

Singhalak Sirisut

(1)

Sinohydro Foundation Engi

(1)

Sirio Pharma Co Ltd

(1)

Sloan Kettering Inst For

(1)

Soc D Exploitation De Pro

(1)

Soleno Therapeutics Inc

(1)

Country

X

China Patent News

WIPO Patent News

European Patent News

Australia Patent News

Status

X

1 - 100 of 1581 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

Tianjin University Files Chinese Patent Application for Self-attention Layer Operator Fusion Optimization Method for FT-Matrix Accelerator

Pharmaceutical

| Sun 18 Oct 2026

Beijing, Oct. 17 -- Tianjin University has filed a patent application for Self-attention Layer Operator Fusion Optimization Method for FT-Matrix Accelerator. This invention was developed by Zeng Yao, Hou Qingzhi and Li Youmeng. The patent application number is CN202610469689 20260410. The patent publication number is CN122347..

State Intellectual Property Office of China Releases Shandong Huanong Biological Pharmaceutical Co Ltd Patent Application for Conveying Type Anti-leakage Traditional Chinese Medici..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Shandong Huanong Biological Pharmaceutical Co Ltd patent application for Conveying Type Anti-leakage Traditional Chinese Medicinal Material Cleaning Equipment. This invention was developed by Zhang Yi, Xu Dongting, Wang Jianwei, Li Tao, Zhu Chuancai and..

Shaanxi Mebo Disinfection Pharmaceutical Group Co Ltd Submits Patent Application for Composition for Removing Pesticide Residues on Fruits and Vegetables as Well as Preparation Met..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Shaanxi Mebo Disinfection Pharmaceutical Group Co Ltd has submitted a patent application for Composition for Removing Pesticide Residues on Fruits and Vegetables as Well as Preparation Method and Application of Composition. Dai Kun and Gao Zhenshan developed the invention. The patent application number is ..

Kaiping Dahao Daily Chemical Tech Co Ltd Submits Patent Application for Chinese Herbal Medicine Extract Synergistic Type Ant Killing Powder

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Kaiping Dahao Daily Chemical Tech Co Ltd has submitted a patent application for Chinese Herbal Medicine Extract Synergistic Type Ant Killing Powder. Ou Ziyang, Qi Zhuoxun, Qi Yifeng, Qi Jiacheng and Qi Qianyi developed the invention. The patent application number is CN202610447813 20260407. The patent publ..

State Intellectual Property Office of China Releases Jinzhong Vocational & Technical College Patent Application for Veterinary Drinking and Dosing Device with High-frequency Micro-..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Jinzhong Vocational & Technical College patent application for Veterinary Drinking and Dosing Device with High-frequency Micro-vibration Precipitation Prevention and Concentration Self-adaptive Medicine Supplement Functions. This invention was developed..

Kite Therapeutics Inc Submits Chinese Patent Application for Compositions and Methods for Muscle Disorders

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Kite Therapeutics Inc has submitted a patent application for Compositions and Methods for Muscle Disorders. This invention was developed by Jenquin Jacques, Marsh Eric and Tabeb De Bal Sabrina. The patent application number is CN20248077971 20241011. The patent publication number is CN122349563 (A). Intern..

Cerbios Pharma SA Submits United States Patent Application for Method for the Production of Pharmaceutically Active Recombinant Human Low Molecular Weight Urokinase

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Cerbios Pharma SA has submitted a patent application for Method for the Production of Pharmaceutically Active Recombinant Human Low Molecular Weight Urokinase. This invention was developed by Durfort Tiphanie, Righetti Luca, Sousa Vitor Lino, Martellato Daniele and Agostinetto Marco. The patent applicat..

U.S. Patent and Trademark Office Releases Yoo Jun Sang and Standup Therapeutics Inc Patent Application for Novel Therapeutic Agent for Parkinson's Disease

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has released Yoo Jun Sang and Standup Therapeutics Inc patent application for Novel Therapeutic Agent for Parkinson's Disease. This invention was developed by Yoo Jun Sang, Shim Hyun Soo, Kim Chunggu, Kim Jong-seo, Na Yongwoo, Chang Yujung and Im Hyeonjoo. The patent app..

Momenta Pharmaceuticals Submits Patent Application for FcRn Antibodies and Methods of Use Thereof

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Momenta Pharmaceuticals has submitted a patent application for FcRn Antibodies and Methods of Use Thereof. Leu Jocelyn H, Ling Leona F, Jin Jianhua, Ramchandren Sindhu, Denney William, Jouvin Marie-helene, Zhu Yaowei, Karcher Keith, Sun Hong, Arroyo Santiago and Black Shawn developed the invention. The ..

Jiangsu Biojetay Biotechnology Co Ltd Submits United States Patent Application for a High-concentration Monoclonal Antibody Formulation and Uses Thereof

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Jiangsu Biojetay Biotechnology Co Ltd has submitted a patent application for a High-concentration Monoclonal Antibody Formulation and Uses Thereof. This invention was developed by Liao Chuan and Li Qinglei. The patent application number is US202318996786 20230727. The patent publication number is US2026..

U.S. Patent and Trademark Office Releases Revopsis Therapeutics Inc Patent Application for Compostions of Multispecific Antigen Binding Polypeptides and Methods of Use

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has released Revopsis Therapeutics Inc patent application for Compostions of Multispecific Antigen Binding Polypeptides and Methods of Use. This invention was developed by Xu Li, Bhandari Ramanath, Palanki Ram Prashanth and Bhatt Ramesh. The patent application number is ..

Immunecare Biopharmaceuticals Shanghai Co Ltd Files United States Patent Application for Recombinant Fusion Protein for Treatment of Pulmonary Hypertension

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Immunecare Biopharmaceuticals Shanghai Co Ltd has filed a patent application for Recombinant Fusion Protein for Treatment of Pulmonary Hypertension. This invention was developed by Li Song, Tian Wenzhi and Chen Dianze. The patent application number is US202419482303 20240408. The patent publication numb..

Previpharma GmbH Submits United States Patent Application for Method for Isolating Fetuin-a

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Previpharma GmbH has submitted a patent application for Method for Isolating Fetuin-a. This invention was developed by Teschner Wolfgang, Reinig Rebecca Michaela, Devarapu Satish Kumar, Berger Tina and Kiessig Stephan T. The patent application number is US202419484066 20240513. The patent publication nu..

Sage Therapeutics LLC Files United States Patent Application for Neuroactive Steroids Substituted in Position 10 with a Cyclic Group for Use in the Treatment of CNS Disorders

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Sage Therapeutics LLC has filed a patent application for Neuroactive Steroids Substituted in Position 10 with a Cyclic Group for Use in the Treatment of CNS Disorders. This invention was developed by Blanco-pillado Maria Jesus, Morningstar Marshall Lee and Salituro Francesco G. The patent application nu..

Nanjing Zaiming Pharmaceutical Co Ltd Files United States Patent Application for BRM Selective Degradation Agent and Use Thereof

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Nanjing Zaiming Pharmaceutical Co Ltd has filed a patent application for BRM Selective Degradation Agent and Use Thereof. This invention was developed by Li Zhengtao, Tang Renhong, Jin Jinghai, Li Yuewen, Mao Jianping, Zeng Fanxun and Zhu Wei. The patent application number is US202419474950 20240412. Th..

Sortec Pharma Sortiertechnik GmbH Submits United States Patent Application for Sorting Device for a Storage System and Storage System with Sorting Device

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Sortec Pharma Sortiertechnik GmbH has submitted a patent application for Sorting Device for a Storage System and Storage System with Sorting Device. This invention was developed by Ottenwälder Thomas and Eisenmann Günter. The patent application number is US202619636407 20260401. The patent publication..

Tianjin University Submits Patent Application for Modified CaFe-LDH Composite Material and Application Thereof in Removing Cd < 2 + > and Cr< 6 + >

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Tianjin University has submitted a patent application for Modified CaFe-LDH Composite Material and Application Thereof in Removing Cd < 2 + > and Cr< 6 + >. Ding Hui, Zhao Dan, Hu Anqi, Chen Yibing, Gao Ge and Dai Chenglong developed the invention. The patent application number is CN202610527202 20260421. ..

Changxing Pharmaceutical Co Ltd Submits Chinese Patent Application for Ceramic Microfiltration Membrane Pressure Control System for Fermentation Liquor Treatment

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Changxing Pharmaceutical Co Ltd has submitted a patent application for Ceramic Microfiltration Membrane Pressure Control System for Fermentation Liquor Treatment. This invention was developed by Tan Cong, Qian Zhongmei, Zhang Likun, Ju Shuyun, Qian Minfan, Yu Liyan, Lu Jiahuan, Yu Haoran, Yang Weihua, Jiang G..

Suzhou Taijing Pharmaceutical Tech Co Ltd Submits Chinese Patent Application for Organic Waste Gas Solvent Recovery Device for Medical Intermediate Processing

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Suzhou Taijing Pharmaceutical Tech Co Ltd has submitted a patent application for Organic Waste Gas Solvent Recovery Device for Medical Intermediate Processing. This invention was developed by Sun Wenjing. The patent application number is CN202610832461 20260610. The patent publication number is CN122351970..

Anhui Xingen Pharmaceutical Co Ltd Submits Patent Application for Water Dust Removal Device Suitable for Traditional Chinese Medicinal Material Stir-frying Machine

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Anhui Xingen Pharmaceutical Co Ltd has submitted a patent application for Water Dust Removal Device Suitable for Traditional Chinese Medicinal Material Stir-frying Machine. Zhang Xiaopeng, Li Peng, Cheng Min, Jiang Tao and Liang Fan developed the invention. The patent application number is CN202610611366 2..

Guangzhou Baokang Pharmaceutical Biotechnology Co Ltd Files Chinese Patent Application for Production Method and Production Equipment of Hair Washing and Caring Product Containing ..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Guangzhou Baokang Pharmaceutical Biotechnology Co Ltd has filed a patent application for Production Method and Production Equipment of Hair Washing and Caring Product Containing Polygonum Multiflorum Extract. This invention was developed by Wang Xiaohui, Fu Weiguo and Zhao Ming. The patent application numb..

First People's Hospital of Changzhou Submits Chinese Patent Application for Pharmaceutical Composition and Application Thereof in Preparation of Medicine for Treating CSVD

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- First People's Hospital of Changzhou has submitted a patent application for Pharmaceutical Composition and Application Thereof in Preparation of Medicine for Treating CSVD. This invention was developed by Qian Wanbin and Chen Xin. The patent application number is CN202610512998 20260417. The patent publica..

Fujian Fuchengrun Biotechnology Co Ltd Submits Chinese Patent Application for Traditional Chinese Medicine Composition for Treating Various Cancers and Preparation Process Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Fujian Fuchengrun Biotechnology Co Ltd has submitted a patent application for Traditional Chinese Medicine Composition for Treating Various Cancers and Preparation Process Thereof. This invention was developed by Gao Yanghua. The patent application number is CN202610788895 20260603. The patent publication ..

Tianjin Eye Hospital Submits Chinese Patent Application for Traditional Chinese Medicine Composition for Treating Uveitis as Well as Preparation Method and Application Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Tianjin Eye Hospital has submitted a patent application for Traditional Chinese Medicine Composition for Treating Uveitis as Well as Preparation Method and Application Thereof. This invention was developed by Pang Yaju and Wang Qimiao. The patent application number is CN202610825526 20260609. The patent pu..

State Intellectual Property Office of China Releases China Resources Jiangzhong Pharmaceutical Co Ltd Patent Application for Compound Extract for Treating Gastric Ulcer as Well as ..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released China Resources Jiangzhong Pharmaceutical Co Ltd patent application for Compound Extract for Treating Gastric Ulcer as Well as Preparation Method and Application Thereof. This invention was developed by Xu Sha, Chen Long, Lin Suqin, Yang Lingyu, Wu Junr..

State Intellectual Property Office of China Releases Beijing Yanshou Health Tech Co Ltd Patent Application for Traditional Chinese Medicine Composition for Resisting Inflammation, ..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Beijing Yanshou Health Tech Co Ltd patent application for Traditional Chinese Medicine Composition for Resisting Inflammation, Relieving Swelling and Pain and Easing Joint Movement, Preparation Method of Traditional Chinese Medicine Composition and Appl..

State Intellectual Property Office of China Releases Shanghai Jiading Nanxiang Hospital Patent Application for Auricular Point Pressing Pill for Treating Epileptic Seizure and Prep..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Shanghai Jiading Nanxiang Hospital patent application for Auricular Point Pressing Pill for Treating Epileptic Seizure and Preparation and Use Methods Thereof. This invention was developed by Wang Jiajun, Tao Jie, Jiang Shasha, Tao Lu, Hou Yangbo, Chen ..

Gao Haijing; Liu Weiji Submits Chinese Patent Application for Five-treasure Pill Prepared by Compatibility of Five Traditional Chinese Medicines Including Astragalus Membranaceus, ..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Gao Haijing; Liu Weiji has submitted a patent application for Five-treasure Pill Prepared by Compatibility of Five Traditional Chinese Medicines Including Astragalus Membranaceus, Rhizoma Polygonati, Prepared Rehmannia Root, Poria Cocos and Pericarpium Citri Reticulatae and Preparation Method of Five-treasure..

Guizhou Jingcheng Pharmaceutical Co Ltd Submits Chinese Patent Application for Application of Xinnaoning Capsule in Preparation of Medicine for Treating Non-alcoholic Fatty Liver D..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Guizhou Jingcheng Pharmaceutical Co Ltd has submitted a patent application for Application of Xinnaoning Capsule in Preparation of Medicine for Treating Non-alcoholic Fatty Liver Disease. This invention was developed by Tu Guoli, Liu Shulin, Xiao Xue, Wang Feng, Tian Yan and Ning Huanhuan. The patent appli..

Jiangxi Provincial Inst Of Traditional Chinese Medicine Files Chinese Patent Application for Process for Cutting Radix Puerariae Thomsonii Medicinal Material While Fresh

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Jiangxi Provincial Inst Of Traditional Chinese Medicine has filed a patent application for Process for Cutting Radix Puerariae Thomsonii Medicinal Material While Fresh. This invention was developed by Xie Yin, Li Xue, Zhang Lubing, Peng Zhixiang, Zhang Yuanyuan, Wang Yamin, Xu Junshen, Wang Xiaoqing, Yang Hai..

Luo Zhanguang Submits Chinese Patent Application for Traditional Chinese Medicine Weight-losing, Health-care and Health-preserving Method for Moxibustion Head Combing and Pedicure ..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Luo Zhanguang has submitted a patent application for Traditional Chinese Medicine Weight-losing, Health-care and Health-preserving Method for Moxibustion Head Combing and Pedicure for Clearing Damp and Raising Yang. This invention was developed by Luo Zhanguang. The patent application number is CN202610641..

Yu Tongdian Submits Chinese Patent Application for Traditional Chinese Medicine Composition for Setting Bones and Treating Burns and Scalds Based on Ancestral Secret Prescription a..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Yu Tongdian has submitted a patent application for Traditional Chinese Medicine Composition for Setting Bones and Treating Burns and Scalds Based on Ancestral Secret Prescription and Application of Traditional Chinese Medicine Composition. This invention was developed by Yu Wenlong and Yu Tongdian. The pat..

TLC Biopharmaceuticals and Taiwan Liposome Co Ltd Files Chinese Patent Application for Liposome Compositions of Intra-articular Corticosteroids for Pain Control

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- TLC Biopharmaceuticals; Taiwan Liposome Co Ltd has filed a patent application for Liposome Compositions of Intra-articular Corticosteroids for Pain Control. This invention was developed by Shi Xuefang, Dai Tianci, Huang Xiaoning, Spence-green George and Gao Kailin. The patent application number is CN202480..

Shandong Simcere Zaiming Bio Pharmaceutical Co Ltd Files Chinese Patent Application for Multi-specific Antibody Composition as Well as Preparation Method and Application Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Shandong Simcere Zaiming Bio Pharmaceutical Co Ltd has filed a patent application for Multi-specific Antibody Composition as Well as Preparation Method and Application Thereof. This invention was developed by Li Xinxin, Ma Fei, Tang Renhong and Hu Jianzhong. The patent application number is CN20248076091 2..

Apmonia Therapeutics Inc Files Chinese Patent Application for Peptide Formulations That Inhibit Tsp-cd47 Interaction

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Apmonia Therapeutics Inc has filed a patent application for Peptide Formulations That Inhibit Tsp-cd47 Interaction. This invention was developed by Dedieu St ¨, Jenny Albin, Phane and Rahgar Abderrahim. The patent application number is CN20248069386 20241031. The patent publication number is CN122349414 (..

Ratio Therapeutics Inc Submits United States Patent Application for 18F-fluorinated Fatty Acids and Uses Thereof

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Ratio Therapeutics Inc has submitted a patent application for 18F-fluorinated Fatty Acids and Uses Thereof. This invention was developed by Coarasa Alejandro Amor. The patent application number is US202318996666 20230719. The patent publication number is US20260308102 (A1). International Patent Classifi..

U.S. Patent and Trademark Office Releases Shanghai Zaimo Biotechnology Co Ltd Patent Application for Camptothecin Drug Conjugate and Use Thereof

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has released Shanghai Zaimo Biotechnology Co Ltd patent application for Camptothecin Drug Conjugate and Use Thereof. This invention was developed by Sun Dapeng. The patent application number is US202619574817 20260323. The patent publication number is US20260306650 (A1)...

Recludix Pharma Submits Patent Application for STAT Degraders and Uses Thereof

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Recludix Pharma has submitted a patent application for STAT Degraders and Uses Thereof. Reznik Samuel K, Tang Yong, Bifulco Neil, Yeoman John, Vaswani Rishi G, Cianchetta Giovanni, Sickmier Ernest Allen, Bregman Howard, Hodous Brian, Tasker Andrew and Tian Xia developed the invention. The patent applica..

U.S. Patent and Trademark Office Releases Auron Therapeutics Inc Patent Application for Technologies Targeting Cell States

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has released Auron Therapeutics Inc patent application for Technologies Targeting Cell States. This invention was developed by Neef James Anthony, Axford Jake Charles, Mcriner Andrew John and Millan David Simon. The patent application number is US202419475567 20240419. T..

Cour Pharmaceuticals Development Co Inc Submits United States Patent Application for Preparation of Tolerizing Nanoparticles for the Treatment of Primary Biliary Cholangitis

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Cour Pharmaceuticals Development Co Inc has submitted a patent application for Preparation of Tolerizing Nanoparticles for the Treatment of Primary Biliary Cholangitis. This invention was developed by Elhofy Adam, Murthy Tushar and Boyne Michael. The patent application number is US202419485809 20240523...

U.S. Patent and Trademark Office Releases Goa Therapeutics Corp Patent Application for Compositions and Methods for Reducing Blood Ethanol Concentration Through Alcohol Dehydrogena..

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has released Goa Therapeutics Corp patent application for Compositions and Methods for Reducing Blood Ethanol Concentration Through Alcohol Dehydrogenase and Acetaldehyde Scavengers. This invention was developed by Ehrmann Barr Tami. The patent application number is US20..

U.S. Patent and Trademark Office Publishes Sanofi Patent Application for FGF21 Compound / GLP-1R Agonist Combinations with Optimized Activity Ratio

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has published Sanofi patent application for FGF21 Compound / GLP-1R Agonist Combinations with Optimized Activity Ratio. The invention was developed by Körner Kathrin. The patent application number is US202619561873 20260310. The patent publication number is US2026030658..

Peroxitech Therapeutics Inc Submits United States Patent Application for Compositions and Methods for Treatment of Septic Shock

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Peroxitech Therapeutics Inc has submitted a patent application for Compositions and Methods for Treatment of Septic Shock. This invention was developed by Han Thomas. The patent application number is US202419481498 20240503. The patent publication number is US20260306579 (A1). International Patent Class..

U.S. Patent and Trademark Office Releases Kwizda Pharma GmbH Patent Application for Production of a Pharmaceutical Dosage Form from Horseradish and Nasturtium

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has released Kwizda Pharma GmbH patent application for Production of a Pharmaceutical Dosage Form from Horseradish and Nasturtium. This invention was developed by Reiss Wolfgang, Feichtinger Silke and Witternigg Anja. The patent application number is US202419483059 20240..

Xie Yuhua Submits United States Patent Application for Chinese Medicine Composition for Dissolving and Excreting Urate Crystals in the Body and Preparation Method Thereof

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Xie Yuhua has submitted a patent application for Chinese Medicine Composition for Dissolving and Excreting Urate Crystals in the Body and Preparation Method Thereof. The patent application number is US202519098252 20250402. The patent publication number is US20260306553 (A1). International Patent Class..

State Intellectual Property Office of China Releases Rongchang Pharmaceutical Zibo Co Ltd Patent Application for Application of Traditional Chinese Medicine Composition in Preparat..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Rongchang Pharmaceutical Zibo Co Ltd patent application for Application of Traditional Chinese Medicine Composition in Preparation of Medicine for Improving Cognitive Impairment. This invention was developed by Yuan Wanwan, Wang Qingxian, Cheng Xiaorui,..

Qinghai Shuliao Intelligent Tech Co Ltd Files Chinese Patent Application for Lung-moistening and Primordial Qi-consolidating Traditional Chinese Medicine Composition Containing Cor..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Qinghai Shuliao Intelligent Tech Co Ltd has filed a patent application for Lung-moistening and Primordial Qi-consolidating Traditional Chinese Medicine Composition Containing Cordyceps Sinensis, Saffron Crocus and Silverweed Cinquefoil Root and Preparation Method Thereof. This invention was developed by Hou L..

Aksu Prefecture Uygur Medicine Hospital Submits Chinese Patent Application for Traditional Chinese Medicine Composition and Application Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Aksu Prefecture Uygur Medicine Hospital has submitted a patent application for Traditional Chinese Medicine Composition and Application Thereof. This invention was developed by Abuletti Celizati, Huganiaz Mehrhaba, Ubuli Alim, Aboulizi Ablaiti and Li Tao. The patent application number is CN202610802792 202..

The First Hospital Of Qiqihar Submits Chinese Patent Application for Traditional Chinese Medicine Composition for Treating Herpes Zoster as Well as Preparation Method and Applicati..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- The First Hospital Of Qiqihar has submitted a patent application for Traditional Chinese Medicine Composition for Treating Herpes Zoster as Well as Preparation Method and Application of Traditional Chinese Medicine Composition. This invention was developed by Zheng Huixuan, Zheng Zhilong and Su Hongli. The..

Zuo Lihua Submits Chinese Patent Application for Borneolum Syntheticum-containing Radix Sanguisorbae-cortex Phellodendri Scald Medicine and Grading Blending and Applying Process Th..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Zuo Lihua has submitted a patent application for Borneolum Syntheticum-containing Radix Sanguisorbae-cortex Phellodendri Scald Medicine and Grading Blending and Applying Process Thereof. This invention was developed by Zuo Lihua. The patent application number is CN202610532910 20260421. The patent publicat..

State Intellectual Property Office of China Releases Guangzhou Hanfang Pharmaceutical Co Ltd Patent Application for Application of Paeoniflorin-6 '-o-benzenesulfonate in Improvemen..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Guangzhou Hanfang Pharmaceutical Co Ltd patent application for Application of Paeoniflorin-6 '-o-benzenesulfonate in Improvement of Alveolar Atrophy Lesion. This invention was developed by Cai Hongfei, Yuan Cheng, He Yingying, Zhang Zhen, Xu Wendong, Ca..

State Intellectual Property Office of China Releases Hangzhou Bangshun Pharmaceutical Co Ltd Patent Application for Compound for Preventing and Treating Diabetes

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Hangzhou Bangshun Pharmaceutical Co Ltd patent application for Compound for Preventing and Treating Diabetes. This invention was developed by Li Bangliang, Zhuge Dingjuan, Zheng Mei, Lyu Yubin, Jiang Shanling and Yin Jianming. The patent application ..

State Intellectual Property Office of China Publishes Shenzhen University Patent Application for Application of Composition of RVX208 and Temozolomide in Preparation of Medicine fo..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has published Shenzhen University patent application for Application of Composition of RVX208 and Temozolomide in Preparation of Medicine for Treating Glioblastoma. The invention was developed by Chen Weilin, Wang Heng and Xiao Yue. The patent application number ..

State Intellectual Property Office of China Releases China Pharmaceutical University Patent Application for Application of Dsasbuvir in Preparation of TRPV4 Inhibitor and Ulcerativ..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released China Pharmaceutical University patent application for Application of Dsasbuvir in Preparation of TRPV4 Inhibitor and Ulcerative Colitis Medicine. This invention was developed by Tang Yong, Wang Yujing, Luo Kexin, Qin Xu, Wang Juan, Ma Weilan, Song Meng..

Chongqing Lianxin Zhikang Biotechnology Co Ltd Files Chinese Patent Application for Emitter for Insulin Pump Remaining Needle

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Chongqing Lianxin Zhikang Biotechnology Co Ltd has filed a patent application for Emitter for Insulin Pump Remaining Needle. This invention was developed by Guo Jinghong, Zeng Zhenggang and Zeng Qi. The patent application number is CN202610822478 20260609. The patent publication number is CN122351636 (A). ..

Chongqing Lianxin Zhikang Biotechnology Co Ltd Submits Patent Application for Clutch Structure for Insulin Pump

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Chongqing Lianxin Zhikang Biotechnology Co Ltd has submitted a patent application for Clutch Structure for Insulin Pump. Guo Jinghong, Deng Lin and Zeng Zhenggang developed the invention. The patent application number is CN202610822475 20260609. The patent publication number is CN122351635 (A). Internation..

Genentech Submits Patent Application for Blind Denoising of Sequencing Data

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Genentech has submitted a patent application for Blind Denoising of Sequencing Data. Kelly Ryan Lewis, Lee Jae Hyeon, Cho Kyunghyun, Ng Nathan Hoyen and Park Ji Won developed the invention. The patent application number is US202519093056 20250327. The patent publication number is US20260311809 (A1). Inter..

Sanofi Seeks Patent for Predicting MRNA Properties Using Large Language Transformer Models

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Sanofi has sought patent for Predicting MRNA Properties Using Large Language Transformer Models. This invention was developed by Jager Sven Frederik, Moayedpour Saeed, Li Sizhen and Bar-joseph Ziv. The patent application number is US202619708745 20260615. The patent publication number is US20260311808 (A1..

Monte Rosa Therapeutics Seeks Patent for Programmable E3 Ligase Identification

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Monte Rosa Therapeutics has sought patent for Programmable E3 Ligase Identification. This invention was developed by Gainza Pablo, Caceres Ramon Miguel and Tsai Jennifer Han-chun. The patent application number is US202419484441 20240516. The patent publication number is US20260311800 (A1). International P..

State Intellectual Property Office of China Releases Shandong Huangshengtang Pharmaceutical Co Ltd Patent Application for Humidity-heat Sterilization Method of Recombinant Collagen..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Shandong Huangshengtang Pharmaceutical Co Ltd patent application for Humidity-heat Sterilization Method of Recombinant Collagen Filler. This invention was developed by Zhu Kunfu, Huang Haohan, Miao Jinlai, Fan Yujiang and Wang Qiguang. The patent app..

State Intellectual Property Office of China Releases Tianjin University Medical Robot and Intelligent System Research Inst Patent Application for Closed-loop Control Method and Dev..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Tianjin University Medical Robot and Intelligent System Research Inst patent application for Closed-loop Control Method and Device for Intraoperative Bleeding Detection and Positioning and Autonomous Hemostasis of Robot-assisted Surgery. This invention ..

Eikon Therapeutics Seeks Patent for Single Molecule Tracking Using Graph Neural Networks

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Eikon Therapeutics has sought patent for Single Molecule Tracking Using Graph Neural Networks. This invention was developed by Godbey Ruth Wendland and Heckert Alec. The patent application number is US202419581008 20240920. The patent publication number is US20260311502 (A1). International Patent Classifi..

Cadrenal Therapeutics Inc Submits United States Patent Application for Oral Pharmaceutical Formulations Containing 4-((2-hydroxy-3-methoxybenzyl)amino) Benzenesulfonamide Derivativ..

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Cadrenal Therapeutics Inc has submitted a patent application for Oral Pharmaceutical Formulations Containing 4-((2-hydroxy-3-methoxybenzyl)amino) Benzenesulfonamide Derivatives. This invention was developed by Boxer Matthew, Flanner Henry and Maloney David. The patent application number is US20231912588..

Viropharma Biologics Llc Submits Patent Application for Stable Corticosteroid Compositions

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Viropharma Biologics Llc has submitted a patent application for Stable Corticosteroid Compositions. Kasina Ramalingeswar developed the invention. The patent application number is US202619640666 20260407. The patent publication number is US20260306511 (A1). International Patent Classification codes are A..

U.S. Patent and Trademark Office Releases Univ Kurume Patent Application for Method of Inhibiting Adenosine Triphosphate Secretion, Method of Inhibiting Hepatic Stellate Cell Activ..

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has released Univ Kurume patent application for Method of Inhibiting Adenosine Triphosphate Secretion, Method of Inhibiting Hepatic Stellate Cell Activation, Method of Deactivating Hepatic Stellate Cell, Method of Treating Hepatic Fibrosis, Method of Treating Non-alcoholic ..

U.S. Patent and Trademark Office Releases Aleksia Therapeutics Inc Patent Application for CDK2 Inhibitor Pyrazolopyrimidine Compounds

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has released Aleksia Therapeutics Inc patent application for CDK2 Inhibitor Pyrazolopyrimidine Compounds. This invention was developed by Phillips Andrew, Kulkarni Santosh S, Lazarski Kiel, Hart Amy, Samanta Swapan Kumar, Quesnelle Claude and Quach Rachelle. The patent a..

Sumitomo Pharma America Submits Patent Application for PIM1 Inhibitor for Treating Myeloproliferative Neoplasms

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Sumitomo Pharma America has submitted a patent application for PIM1 Inhibitor for Treating Myeloproliferative Neoplasms. Mei Jian, Foulks Jason M, Brooks Emily M, Wade Mark L, Lebedinsky Claudia A, Kabir Sujan and Whatcott Clifford J developed the invention. The patent application number is US2023191255..

Tanabe Pharma Corp Submits United States Patent Application for Pharmaceutical Composition for Keratosis and Use Thereof

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Tanabe Pharma Corp has submitted a patent application for Pharmaceutical Composition for Keratosis and Use Thereof. This invention was developed by Saito Ryuta and Matsushita Yasuaki. The patent application number is US202619711644 20260617. The patent publication number is US20260306483 (A1). Internati..

Northwestern University Applies for Patent on Methods of Treating Diseases and Disorders Associated with FoxP3 Expression

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Northwestern University has applied United States patent for Methods of Treating Diseases and Disorders Associated with FoxP3 Expression. Fang Deyu, Zhang Xiaoyu, Tang Amy and Gao Beixue developed it. The patent application number is US202619636687 20260401. The patent publication number is US2026030648..

Minoryx Therapeutics S L Submits Patent Application for Polymorphic Forms and Formulations of Leriglitazone

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Minoryx Therapeutics S L has submitted a patent application for Polymorphic Forms and Formulations of Leriglitazone. Martí Pérez Montserrat and Fábregas Vidal José Luis developed the invention. The patent application number is US202419482358 20240509. The patent publication number is US20260306468 (..

Cinclus Pharma Holding AB (publ) Submits United States Patent Application for Linaprazan Glurate for Treating Gastroesophageal Reflux Disease (gerd)

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Cinclus Pharma Holding AB (publ) has submitted a patent application for Linaprazan Glurate for Treating Gastroesophageal Reflux Disease (gerd). This invention was developed by Unge Peter and Andersson Kjell. The patent application number is US202319482301 20231103. The patent publication number is US202..

U.S. Patent and Trademark Office Publishes Atai Therapeutics Patent Application for N-n-dimethyltryptamine (DMT) and DMT Analog Oral Transmucosal Film Compositions, Methods of Maki..

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- U.S. Patent and Trademark Office has published Atai Therapeutics patent application for N-n-dimethyltryptamine (DMT) and DMTAnalog Oral Transmucosal Film Compositions, Methods of Making, and Methods of Use Thereof. The invention was developed by Zheng Rubo, Saxena Vaibhav and Paiement Nadine. The patent..

Beckley Psytech Applies for Patent on 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) Pharmaceutical Compositions

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Beckley Psytech has applied United States patent for 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) Pharmaceutical Compositions. Feilding-mellen Cosmo and Mason Timothy developed it. The patent application number is US202419479001 20240429. The patent publication number is US20260306452 (A1). Internationa..

Somerset Therapeutics LLC Files United States Patent Application for Compositions for the Effective Treatment of Vitamin C Deficiency-related Diseases and Other Conditions

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Somerset Therapeutics LLC has filed a patent application for Compositions for the Effective Treatment of Vitamin C Deficiency-related Diseases and Other Conditions. This invention was developed by Subramanian Veerappan, Subramanian Ilango, Kalhapure Rahul and Trehan Aman. The patent application number i..

Towa Pharmaceutical Co Ltd Submits Patent Application for Drug-containing Particle

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Towa Pharmaceutical Co Ltd has submitted a patent application for Drug-containing Particle. Honjo Tatsuya, Yuminoki Kayo, Okuda Yutaka, Saeki Isamu and Hiraishi Keisuke developed the invention. The patent application number is US202619706793 20260612. The patent publication number is US20260306409 (A1)...

Shanxi Medical University Seeks Patent for Application of ULK3 Inhibitor in Preparation of Medicine for Treating or Improving Chronic Kidney Disease

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Shanxi Medical University has sought patent for Application of ULK3 Inhibitor in Preparation of Medicine for Treating or Improving Chronic Kidney Disease. This invention was developed by Ge Rui, Tang Li, Li Qingshan, Ren Zhichao, Feng Xiue, Han Lingge and Yang Yichen. The patent application number is CN202..

Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences Submits Patent Application for Application of Furocoumarin Compound in Medicine for Preventing and/or Treating Ne..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences has submitted a patent application for Application of Furocoumarin Compound in Medicine for Preventing and/or Treating Neuroinflammation Related Diseases. Yang Junli, Wang Xingrong, Hou Yongsheng and Liu Jiaqi developed the invention. The p..

State Intellectual Property Office of China Releases Hospital Affiliated To Fuzhou Univ Patent Application for Application of Myrotoxin a in Preparation of Medicine for Treating Pr..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Hospital Affiliated To Fuzhou Univ patent application for Application of Myrotoxin a in Preparation of Medicine for Treating Prostatic Cancer. This invention was developed by Ye Liefu, Zhu Qingguo, Lin Deng, Lu Zhonglei, Yang Yaojing, Lin Ting, Zhuang S..

University of South China Seeks Patent for 2, 3, 4apos; Application Of-dihydroxyflavone in Preparation of Medicine for Preventing and/or Treating Ulcerative Colitis

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- University of South China has sought patent for 2, 3, 4apos; Application Of-dihydroxyflavone in Preparation of Medicine for Preventing and/or Treating Ulcerative Colitis. This invention was developed by Su Shijie, Zhu Lijuan and Wang Zijun. The patent application number is CN202610671201 20260515. The pate..

Kunming Medical University Submits Chinese Patent Application for Application of Forskolin and/or Isoforskolin in Preparation of Medicine for Preventing and/or Treating Colitis

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Kunming Medical University has submitted a patent application for Application of Forskolin and/or Isoforskolin in Preparation of Medicine for Preventing and/or Treating Colitis. This invention was developed by Zhang Ye, Li Shuyi, Yang Weimin, Liu Zhenhua, Long Yun, Zou Shuwei, Liang Yaping, Hua Yingxin, Wang ..

West China Hospital, Sichuan University Submits Chinese Patent Application for Application of LDHA Inhibitor in Preparation of Medicine for Preventing or Treating Dry Age-related M..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- West China Hospital, Sichuan University has submitted a patent application for Application of LDHA Inhibitor in Preparation of Medicine for Preventing or Treating Dry Age-related Macular Degeneration. This invention was developed by Xu Hanyue, Huang Yufan, Yan Naihong, Xiao Lirong, Zhang Ming and Chen Yi. ..

State Intellectual Property Office of China Releases Beijing Friendship Hospital, Capital Medical University Patent Application for Application of Hinokitiol or Derivative Thereof ..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Beijing Friendship Hospital, Capital Medical University patent application for Application of Hinokitiol or Derivative Thereof in Preparation of Medicine for Inhibiting Drp1-mediated Excessive Mitochondrial Division. This invention was developed by Xu J..

State Intellectual Property Office of China Releases Changzhou Yinsheng Pharmaceutical Co Ltd Patent Application for Tadalafil Tablet and Preparation Method Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Changzhou Yinsheng Pharmaceutical Co Ltd patent application for Tadalafil Tablet and Preparation Method Thereof. This invention was developed by Jiang Yanhua, Wu Jinggang and Han Jiaqi. The patent application number is CN202610783203 20260602. The pa..

Shandong Sbond Pharmaceutical Co Ltd Submits Chinese Patent Application for Metformin Empagliflozin Tablet and Fluidized Bed-based Preparation Process Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Shandong Sbond Pharmaceutical Co Ltd has submitted a patent application for Metformin Empagliflozin Tablet and Fluidized Bed-based Preparation Process Thereof. This invention was developed by Yuan Wujie, Qiao Min, Li Guiying, Yuan Jingyao and Liu Ruimin. The patent application number is CN202610824849 2026..

State Intellectual Property Office of China Releases Nanjing Zeheng Pharmaceutical Science & Tech Co Ltd Patent Application for Preparation Method of Sulindac Tablet Composition

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Nanjing Zeheng Pharmaceutical Science & Tech Co Ltd patent application for Preparation Method of Sulindac Tablet Composition. This invention was developed by Xu Cheng, Gao Peng, Tang Yan and Mou Yingbo. The patent application number is CN202610704025..

Anhui Zhihuo Pharmaceutical Tech Co Ltd Submits Patent Application for Application of Pharmaceutical Preparation Containing Icaritin in Tumor Cachexia

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Anhui Zhihuo Pharmaceutical Tech Co Ltd has submitted a patent application for Application of Pharmaceutical Preparation Containing Icaritin in Tumor Cachexia. Wang Yunsheng developed the invention. The patent application number is CN202610832679 20260610. The patent publication number is CN122351176 (A). ..

Hebei Daoen Pharmaceutical Co Ltd Files Chinese Patent Application for Eribulin Mesylate Liposome as Well as Preparation Method and Application Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Hebei Daoen Pharmaceutical Co Ltd has filed a patent application for Eribulin Mesylate Liposome as Well as Preparation Method and Application Thereof. This invention was developed by Feng Xuemei, Wu Kedi, Hou Xicheng, Wang Zhengang, Wang Yifan and Wang Runwei. The patent application number is CN20251035099..

Guangzhou Hejiarunyan Pharmaceutical Co Ltd Submits Chinese Patent Application for Preparation Method of Soybean Extract Fermentation Product, Anti-aging Composition and Applicatio..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Guangzhou Hejiarunyan Pharmaceutical Co Ltd has submitted a patent application for Preparation Method of Soybean Extract Fermentation Product, Anti-aging Composition and Application of Anti-aging Composition. This invention was developed by He Beizhan and Liu Mushui. The patent application number is CN2026..

State Intellectual Property Office of China Releases Tianjin University Medical Robot And Intelligent System Research Inst Patent Application for Multi-mode Integrated Minimally In..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Tianjin University Medical Robot And Intelligent System Research Inst patent application for Multi-mode Integrated Minimally Invasive Laser Ablation Device. This invention was developed by Li Jinhua, Zhao Jianchang, Pan Lizhi, Shi Zitan and He Yushi. ..

Zhangzhou Pien Tze Huang Pharmaceutical Submits Chinese Patent Application for Forest Musk Deer Lung Monitoring System Based on Portable DR Technology

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Zhangzhou Pien Tze Huang Pharmaceutical has submitted a patent application for Forest Musk Deer Lung Monitoring System Based on Portable DR Technology. This invention was developed by Liu Shuqiang, Zhang Zexiu, Ye Sen, Zhao Yuetong, Li Cong, Cao Jia, Li Xuxin, Han Yingying, Hu Jingyao, Dou Xinyue and Zhang Ye..

Shaanxi Xingfudao Smart Tech Co Ltd Submits Chinese Patent Application for Traditional Chinese Medicine Physique Intelligent Identification and Dynamic Interpretable Conditioning S..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Shaanxi Xingfudao Smart Tech Co Ltd has submitted a patent application for Traditional Chinese Medicine Physique Intelligent Identification and Dynamic Interpretable Conditioning Scheme Generation System. This invention was developed by Zhu Jiaqi, Ren Jun, Sun Chao, Mao Luning and Mi Hailong. The patent ap..

Genentech Applies for Patent on Population PK/PD Linking Parameter Analysis Using Deep Learning

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Genentech has applied United States patent for Population PK/PD Linking Parameter Analysis Using Deep Learning. Lu James developed it. The patent application number is US202519366285 20251022. The patent publication number is US20260311820 (A1). International Patent Classification codes are G16C20/50 an..

Tianjin University Zhejiang Research Inst Shaoxing Files Chinese Patent Application for 50ppm Deuterium-depleted Water Injection and Preparation Method Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Tianjin University Zhejiang Research Inst Shaoxing has filed a patent application for 50ppm Deuterium-depleted Water Injection and Preparation Method Thereof. This invention was developed by Wang Jiakang, Bai Peng, Liu Yongqing, Jiang Xiangsu and Wang Li. The patent application number is CN202610562751 202..

North China Pharmaceutical Qinghuadao Co Ltd Submits Chinese Patent Application for Skin Cream for Rhagadia Manus and Pedis and Preparation Process Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- North China Pharmaceutical Qinghuadao Co Ltd has submitted a patent application for Skin Cream for Rhagadia Manus and Pedis and Preparation Process Thereof. This invention was developed by Liu Zhongsheng, Liu Cuimei, Zhang Yanjin, Zhang Liyuan, Fu Jialin, Xue Yanan, Ma Shasha, Ren Chao, Guo Weiguang, Ping Xia..

Guangzhou Huamei Pharmaceutical Biotechnology Co Ltd Submits Chinese Patent Application for Anti-dandruff and Itching-relieving Essence Liquid with Anti-inflammatory and Antibacter..

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Guangzhou Huamei Pharmaceutical Biotechnology Co Ltd has submitted a patent application for Anti-dandruff and Itching-relieving Essence Liquid with Anti-inflammatory and Antibacterial Effects. This invention was developed by Sun Kaijun. The patent application number is CN202610505457 20260416. The patent p..

University of Chicago Files United States Patent Application for Engineered Compact CRISPR-cas12f System

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- University of Chicago has filed a patent application for Engineered Compact CRISPR-cas12f System. This invention was developed by Tang Weixin, Wu Tong and Zou Siyuan. The patent application number is US202419479435 20240430. The patent publication number is US20260308554 (A1). International Patent Class..

Gilead Sciences Submits Patent Application for Crystalline Forms of a PARP1 Inhibitor

Pharmaceutical

| Sun 18 Oct 2026

Alexandria, Oct. 17 -- Gilead Sciences has submitted a patent application for Crystalline Forms of a PARP1 Inhibitor. Liu Jing, Reddy Jayachandra P and Kocevska Stefani developed the invention. The patent application number is US202519428821 20251222. The patent publication number is US20260308163 (A1). International Patent C..

State Intellectual Property Office of China Releases Zhejiang University Patent Application for Drug Delivery System Based on Brain Microvascular Endothelial Cells and Application

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has released Zhejiang University patent application for Drug Delivery System Based on Brain Microvascular Endothelial Cells and Application. This invention was developed by Li Yaosheng, Jiang Xinchi and Gao Jianqing. The patent application number is CN20251129046..

State Intellectual Property Office of China Receives Eisai R&D Management Patent Application for Antibody-drug Conjugate Metabolites

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- State Intellectual Property Office of China has received Eisai R&D Management patent application for Antibody-drug Conjugate Metabolites. Fernando Sabrina and Albone Eugene F developed the invention. The patent application number is CN20248077409 20241011. The patent publication number is CN122349614 (A). ..

Mingji Xian Biotechnology Dev Co Ltd Applies for Patent on External-use Pain-relieving Soothing Smearing Liquid and Preparation Method Thereof

Pharmaceutical

| Sat 17 Oct 2026

Beijing, Oct. 17 -- Mingji Xian Biotechnology Dev Co Ltd has applied Chinese patent for External-use Pain-relieving Soothing Smearing Liquid and Preparation Method Thereof. Zhao Zhenyu, Zhao Jingyu, Xiang Rong and Zhao Xiaoming developed it. The patent application number is CN202610670641 20260515. The patent publication numb..

1 to 100 of 1581 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles